A chemotherapy drug often used in newly diagnosed CML for an initial very short period before the start of TKI therapy in order to reduce high white cell counts; it does not have any cytogenetic effect on the disease.
A chemotherapy drug often used in newly diagnosed CML for an initial very short period before the start of TKI therapy in order to reduce high white cell counts; it does not have any cytogenetic effect on the disease.
There is currently no content classified with this term.